Calavo Growers (CVGW)
(Delayed Data from NSDQ)
$27.03 USD
-0.38 (-1.39%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $26.99 -0.04 (-0.15%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Income Statements
Fiscal Year end for Calavo Growers, Inc falls in the month of October .
All items in Millions except EPS data.
10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 | |
---|---|---|---|---|---|
Sales | 972 | 1,191 | 1,056 | 1,059 | 1,196 |
Cost Of Goods | 902 | 1,117 | 998 | 969 | 1,068 |
Gross Profit | 70 | 74 | 57 | 90 | 128 |
Selling & Adminstrative & Depr. & Amort Expenses | 70 | 68 | 67 | 58 | 57 |
Income After Depreciation & Amortization | 0 | 6 | -10 | 32 | 71 |
Non-Operating Income | 1 | -7 | 11 | -43 | -7 |
Interest Expense | 3 | 2 | 1 | 1 | 1 |
Pretax Income | -1 | -3 | 1 | -12 | 64 |
Income Taxes | 6 | 3 | 11 | -4 | 13 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | -1 | -1 | -2 | -6 | -14 |
Income From Cont. Operations | -8 | -7 | -12 | -14 | 37 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -8 | -6 | -12 | -14 | 37 |
Depreciation Footnote | 10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 18 | 23 | 8 | 48 | 85 |
Depreciation & Amortization (Cash Flow) | 17 | 17 | 18 | 16 | 14 |
Income After Depreciation & Amortization | 0 | 6 | -10 | 32 | 71 |
Earnings Per Share Data | 10/31/23 | 10/31/22 | 10/31/21 | 10/31/20 | 10/31/19 |
---|---|---|---|---|---|
Average Shares | 17.75 | 17.66 | 17.62 | 17.56 | 17.59 |
Diluted EPS Before Non-Recurring Items | -0.01 | 0.50 | 0.35 | 1.57 | 3.02 |
Diluted Net EPS (GAAP) | -0.47 | -0.35 | -0.67 | -0.78 | 2.08 |
Fiscal Year end for Calavo Growers, Inc falls in the month of October .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 127.61 | 241.18 | 259.88 | 244.69 | 226.20 |
Cost Of Goods | 115.14 | 225.72 | 234.85 | 229.65 | 211.77 |
Gross Profit | 12.47 | 15.46 | 25.02 | 15.04 | 14.43 |
SG&A, R&D, and Dept/Amort Expenses | 13.85 | 16.03 | 16.64 | 18.46 | 18.40 |
Income After SG&A, R&D, and Dept/Amort Expenses | -1.38 | -0.57 | 8.38 | -3.42 | -3.97 |
Non-Operating Income | 0.20 | -0.55 | 0.23 | 0.28 | 0.35 |
Interest Expense | 0.82 | 1.01 | 0.79 | 0.27 | 0.42 |
Pretax Income | -2.00 | -1.52 | 7.82 | -3.42 | -4.03 |
Income Taxes | 0.57 | 5.92 | 0.62 | 0.48 | -1.08 |
Minority Interest | 0.01 | -0.01 | 0.08 | 0.04 | 0.27 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | -0.48 | -0.50 | -0.06 | 0.16 |
Income From Cont. Operations | -2.57 | -7.92 | 6.71 | -3.96 | -2.80 |
Extras & Discontinued Operations | -3.68 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -6.27 | -7.91 | 6.63 | -4.00 | -3.07 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 17.80 | 17.77 | 17.86 | 17.72 | 17.67 |
Diluted EPS Before Non-Recurring Items | -0.01 | -0.33 | 0.41 | -0.01 | -0.08 |
Diluted Net EPS (GAAP) | -0.35 | -0.44 | 0.37 | -0.23 | -0.17 |